March 2018 FDA Recall Indomethacin by Glenmark Pharmaceuticals Inc., Usa
D-0606-2018 - Labeling

This Class III drug recall was voluntarily initiated by Glenmark Pharmaceuticals Inc., Usa on March 19, 2018 for the product Indomethacin. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0606-2018

Reason for Recall
Labeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day." rather than the correct usual adult dosage of "One capsule 2 or 3 times a day.
Initiated
03-19-2018
Reported
04-04-2018
Quantity
109,080 Bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Glenmark Pharmaceuticals Inc., USA
Nationwide in the United States.
Indomethacin Capsules USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-302-01.

Batch or Lot Expiration Information

Lot# : 19172776, 19172794, Exp 07/19; 19173111, 19173186, 19173188, 19173189, Exp 08/19; 19173852, 19173878, 19173893, Exp 10/19; 19174318, 19174341, Exp 11/19.